All articles by Chia Lin
Chia Lin
Over 2,000 drugs in Japan undergo an average price reduction of 9.4% in April
Historically, Japan performs scheduled biannual price adjustments as a cost-reduction method.
Warnings for Japanese pharmaceutical market may lead to more lenient price controls
The OPIR report showed that Japan’s pricing policy has raised serious concern among large multinational pharmaceutical companies.